CMS lists drug tests and their correct codes, but no new guidelines

Article Overview

This article summarizes a CMS update about billing for drug screening tests and the interim guidance that was issued to address recently added drug test codes. It is relevant to practices and coders who follow Medicare billing policy, because it explains that CMS still had not released final direction at the time of publication and had instead issued a transmittal listing tests associated with each drug code. The piece is a brief policy news item rather than a detailed technical coding guide.